260 related articles for article (PubMed ID: 26960286)
1. Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution.
Shimato S; Nishizawa T; Ohshima T; Imai T; Goto S; Yamamoto T; Kato K
World Neurosurg; 2016 Jun; 90():340-347. PubMed ID: 26960286
[TBL] [Abstract][Full Text] [Related]
2. Importance and accuracy of intraoperative frozen section diagnosis of the resection margin for effective carmustine wafer implantation.
Asano K; Kurose A; Kamataki A; Kato N; Ogawa K; Katayama K; Kakuta K; Fumoto T; Ohkuma H
Brain Tumor Pathol; 2018 Jul; 35(3):131-140. PubMed ID: 29948295
[TBL] [Abstract][Full Text] [Related]
3. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
[TBL] [Abstract][Full Text] [Related]
4. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.
Shibahara I; Hanihara M; Watanabe T; Dan M; Sato S; Kuroda H; Inamura A; Inukai M; Hara A; Yasui Y; Kumabe T
J Neurooncol; 2018 Apr; 137(2):417-427. PubMed ID: 29468445
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers.
Murai S; Ichikawa T; Kurozumi K; Shimazu Y; Oka T; Otani Y; Shimizu T; Date I
J Clin Neurosci; 2016 Nov; 33():148-153. PubMed ID: 27452129
[TBL] [Abstract][Full Text] [Related]
7. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma.
Shibahara I; Miyasaka K; Sekiguchi A; Ishiyama H; Inukai M; Yasui Y; Watanabe T; Sato S; Hide T; Kumabe T
J Clin Neurosci; 2021 Apr; 86():202-210. PubMed ID: 33775329
[TBL] [Abstract][Full Text] [Related]
9. Incorporating BCNU wafers into malignant glioma treatment: European case studies.
Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J
Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992
[TBL] [Abstract][Full Text] [Related]
10. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
[TBL] [Abstract][Full Text] [Related]
11. Growth pattern of tumor recurrence following bis-chloroethylnitrosourea (BCNU) wafer implantation in malignant glioma.
Dörner L; Mustafa A; Rohr A; Mehdorn HM; Nabavi A
J Clin Neurosci; 2013 Mar; 20(3):429-34. PubMed ID: 23313517
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence.
Ohue S; Kohno S; Inoue A; Yamashita D; Suehiro S; Seno T; Kumon Y; Kikuchi K; Ohnishi T
J Neurooncol; 2016 Jan; 126(1):119-126. PubMed ID: 26384812
[TBL] [Abstract][Full Text] [Related]
13. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Westphal M; Hilt DC; Bortey E; Delavault P; Olivares R; Warnke PC; Whittle IR; Jääskeläinen J; Ram Z
Neuro Oncol; 2003 Apr; 5(2):79-88. PubMed ID: 12672279
[TBL] [Abstract][Full Text] [Related]
14. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.
Sabel M; Giese A
Curr Med Res Opin; 2008 Nov; 24(11):3239-57. PubMed ID: 18940042
[TBL] [Abstract][Full Text] [Related]
15. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
Giese A; Bock HC; Kantelhardt SR; Rohde V
Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative pathological diagnosis in 205 glioma patients in the pre-BCNU wafer era: retrospective analysis with intraoperative implantation of BCNU wafers in mind.
Ishikawa E; Yamamoto T; Satomi K; Matsuda M; Akutsu H; Shibuya M; Nakai K; Sakamoto N; Takano S; Matsumura A
Brain Tumor Pathol; 2014 Jul; 31(3):156-61. PubMed ID: 24535160
[TBL] [Abstract][Full Text] [Related]
17. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
[TBL] [Abstract][Full Text] [Related]
18. Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study.
Bock HC; Cohnen J; Keric N; Kantelhardt SR; Giese A
Acta Neurochir (Wien); 2011 Mar; 153(3):533-9. PubMed ID: 21210161
[TBL] [Abstract][Full Text] [Related]
19. Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma.
Klein J; Juratli TA; Radev Y; Daubner D; Soucek S; Schackert G; Krex D
Oncology; 2017; 93(1):43-50. PubMed ID: 28395288
[TBL] [Abstract][Full Text] [Related]
20. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma.
Engelhard HH
Surg Neurol; 2000 May; 53(5):458-64. PubMed ID: 10874145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
